NLS

Åse Solberg currently works as Senior Advisor at Legemiddelindustrien (LMI), the Norwegian pharmaceutical industry association, and previously served as Communications Advisor to The Life Science Cluster.

The Directed Issue has been directed to existing shareholders and a new investor and is carried out at a subscription price corresponding to a premium of approximately 4.08 percent compared with the latest closing price.

Alzinova has entered into a non-binding Letter of Intent with Fujirebio, a global provider of in vitro diagnostic solutions, regarding the potential development and commercialization of a blood-based diagnostic test for Alzheimer’s disease based on Alzinova’s Aβ42CC oligomer technology.

FluoGuide has announced positive results from the first part of its ongoing FG001-CT-005 Phase 2 trial evaluating FG001 for surgical guidance in patients with oral head and neck cancer.

For 20 years, we have covered the Nordic region, giving readers a full and balanced perspective on the life science industry. Recent events have prompted us to reflect on our name and what it stands for.

Nordic Growth Market NGM AB has granted conditional approval for NOSIUM AB – which is in the process of changing its name to Medicortex International AB – to continue trading on NGM Growth Market following completion of its reverse takeover of Medicortex Finland.